Online citations, reference lists, and bibliographies.
← Back to Search

Utilizing A Regulated Targeted Integration Cell Line Development Approach To Systematically Investigate What Makes An Antibody Difficult To Express

T. Tadauchi, Cynthia Lam, Laura Liu, Y. Zhou, D. Tang, S. Louie, B. Snedecor, S. Misaghi
Published 2019 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Chinese hamster ovary (CHO) cells are conventionally used to generate therapeutic cell lines via random integration (RI), where desired transgenes are stably integrated into the genome. Targeted integration (TI) approaches, which involve integration of a transgene into a specific locus in the genome, are increasingly utilized for CHO cell line development (CLD) in recent years. None of these CLD approaches, however, are suitable for expression of toxic or difficult‐to‐express molecules, or for determining the underlying causes for poor expression of some molecules. Here we introduce a regulated target integration (RTI) system, where the desired transgene is integrated into a specific locus and transcribed under a regulated promoter. This system was used to determine the underlying causes of low protein expression for a difficult‐to‐express antibody (mAb‐A). Interestingly, we observed that both antibody heavy chain (HC) and light chain (LC) subunits of mAb‐A independently contributed to its low expression. Analysis of RTI cell lines also revealed that while mAb‐A LC triggered accumulation of intracellular BiP, its HC displayed impaired degradation and clearance. RTI pools, generated by swapping the WT or point‐mutant versions of difficult‐to‐express antibody HC and LC with that of an average antibody, were instrumental in understanding the contribution of HC and LC subunits to the overall antibody expression. The ability to selectively turn off the expression of a target transgene in an RTI system could help to directly link expression of a transgene to an observed adverse effect. © 2018 American Institute of Chemical Engineers Biotechnol. Prog., 35: e2772, 2019.
This paper references
Co-expression and amplification of dihydrofolate reductase cDNA and the Escherichia coli XGPRT gene in Chinese hamster ovary cells.
G. Ringold (1981)
Immunoglobulin heavy chain binding protein
Ingrid G. Haas (1983)
Transfected DNA is mutated in monkey, mouse, and human cells.
J. Lebkowski (1984)
Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas
D. Bole (1986)
High Level Expression of Tissue Inhibitor of Metalloproteinases in Chinese Hamster Ovary Cells Using Glutamine Synthetase Gene Amplification
M. Cockett (1990)
Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus.
R. Kaufman (1991)
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
M. Gossen (1992)
Interaction of BiP with newly synthesized immunoglobulin light chain molecules: cycles of sequential binding and release.
M. Knittler (1992)
Transcriptional activation by tetracyclines in mammalian cells.
M. Gossen (1995)
Repeat-induced gene silencing in mammals
D. Garrick (1998)
Chromatin as a eukaryotic template of genetic information.
Giacomo Cavalli (2002)
Post-translational modifications in the context of therapeutic proteins
G. Walsh (2006)
Recombinant protein expression by targeting pre-selected chromosomal loci
K. Nehlsen (2009)
Expression systems for therapeutic glycoprotein production.
Y. Durocher (2009)
Therapeutic antibodies for autoimmunity and inflammation
A. Chan (2010)
Detecting low level sequence variants in recombinant monoclonal antibodies
Yi Yang (2010)
Towards rational engineering of cells: Recombinant gene expression in defined chromosomal loci
K. Nehlsen (2011)
Promoter methylation and transgene copy numbers predict unstable protein production in recombinant chinese hamster ovary cell lines
Andrea Osterlehner (2011)
Immunoglobulin Free Light Chain Dimers in Human Diseases
B. Kaplan (2011)
CHO cells in biotechnology for production of recombinant proteins: current state and further potential
J. Y. Kim (2011)
Fast identification of reliable hosts for targeted cell line development from a limited‐genome screening using combined φC31 integrase and CRE‐Lox technologies
Y. Crawford (2013)
Advances in Mammalian Cell Line Development Technologies for Recombinant Protein Production
Tingfeng Lai (2013)
It's time to regulate: Coping with product‐induced nongenetic clonal instability in CHO cell lines via regulated protein expression
Shahram Misaghi (2014)
CHO cell engineering to prevent polypeptide aggregation and improve therapeutic protein secretion.
Valérie Le Fourn (2014)
Model‐directed engineering of “difficult‐to‐express” monoclonal antibody production by Chinese hamster ovary cells
Leon P. Pybus (2014)
Recombinase‐mediated cassette exchange (RMCE) for monoclonal antibody expression in the commercially relevant CHOK1SV cell line
L. Zhang (2015)
Taming hyperactive hDNase I: Stable inducible expression of a hyperactive salt‐ and actin‐resistant variant of human deoxyribonuclease I in CHO cells
Cynthia Lam (2017)
Strategies and Considerations for Improving Expression of "Difficult to Express" Proteins in CHO Cells.
C. Alves (2017)
A novel Bxb1 integrase RMCE system for high fidelity site‐specific integration of mAb expression cassette in CHO Cells
Mara C. Inniss (2017)
Investigation of the free heavy chain homodimers of a monoclonal antibody
Hyo (Helen) Chung (2018)
The Unfolded Protein Response and Cell Fate Control.
C. Hetz (2018)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar